NEW YORK, Feb. 18, 2021 /PRNewswire/ -- Adjuvant Capital today announced an oversubscribed $300 million fund focused on accelerating the development of medical innovations for historically overlooked public health challenges. Launched in 2019, Adjuvant's debut fund will support promising...